Key result
Cardiomyocyte-specific AT1R overexpression led to a significantly higher mortality rate in female mice (21.0%) compared to male mice (5.5%), driven by more severe eccentric hypertrophy.
Why the study?
Does female sex increase susceptibility to dilated cardiomyopathy and mortality in mice with cardiac-specific AT1R overexpression compared to males?
Does female sex increase susceptibility to dilated cardiomyopathy and mortality in mice with cardiac-specific AT1R overexpression compared to males?
Absolute Event Rate: 21% vs 5.5%
p-value: p=0.0036
Female mice with AT1R overexpression exhibit higher mortality and more severe eccentric hypertrophy and calcium handling dysfunction than males, highlighting sex-specific susceptibilities in heart failure development.
Suggests greater female susceptibility to AT1R-driven mortality in mice; leaves open relevance to human cardiomyopathy.
Heart failure (HF) is associated with high mortality and affects men and women differently. The underlying mechanisms for these sex-related differences remain largely unexplored. Accordingly, using mice with cardiac-specific overexpression of the angiotensin II (ANGII) type 1 receptor (AT1R), we explored male-female differences in the manifestations of hypertrophy and HF. AT1R mice of both sexes feature electrical and Ca 2+ handling alterations, systolic dysfunction, hypertrophy and develop HF. However, females had much higher mortality (21.0%) rate than males (5.5%). In females, AT1R stimulation leads to more pronounced eccentric hypertrophy (larger increase in LV mass/body weight ratio [+31%], in cell length [+27%], in LV internal end-diastolic [LVIDd, +34%] and systolic [LVIDs, +67%] diameter) and dilation (larger decrease in LV posterior wall thickness, +17%) than males. In addition, in female AT1R mice the cytosolic Ca 2+ extrusion mechanisms were more severely compromised and were associated with a specific increased in Ca 2+ sparks (by 187%) and evidence of SR Ca 2+ leak. Altogether, these results suggest that female AT1R mice have more severe eccentric hypertrophy, dysfunction and compromised Ca 2+ dynamics. These findings indicate that females are more susceptible to the adverse effects of AT1R stimulation than males favouring the development of HF and increased mortality.
No takes yet. Share an insight, caveat, or question.
Mathieu et al. (2018) studied Heart failure and dilated cardiomyopathy (n=389). Cardiomyocyte-specific AT1R overexpression vs. Male AT1R mice and wild-type controls was evaluated on Mortality rate at 15 months (p=0.0036). Cardiomyocyte-specific AT1R overexpression led to a significantly higher mortality rate in female mice (21.0%) compared to male mice (5.5%), driven by more severe eccentric hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: